The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sensitivity of second-generation blood-based methylated Septin9 assay for early-stage colorectal cancer.
Gunter Weiss
Stock Ownership - Epigenomics
Anne Fassbender
Stock Ownership - Epigenomics
Thomas Koenig
Stock Ownership - Epigenomics
Reimo Tetzner
Stock Ownership - Epigenomics